• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素从可膨胀交联淀粉微球中的控释动力学。

Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.

作者信息

Bajpai A K, Bhanu Smitha

机构信息

Bose Memorial Research Laboratory, Department of Chemistry, Government Autonomous Science College, Jabalpur, MP 482001, India.

出版信息

J Mater Sci Mater Med. 2007 Aug;18(8):1613-21. doi: 10.1007/s10856-007-3020-y. Epub 2007 May 5.

DOI:10.1007/s10856-007-3020-y
PMID:17483909
Abstract

The microspheres of crosslinked starch have been prepared and characterized by IR spectral analysis and SEM technique. The prepared microspheres were loaded with an anticoagulant drug 'heparin' and the kinetics of in-vitro release of heparin was investigated spectrophotometrically at physiological pH (7.4) and body temperature (37 degrees C). The influence of percent loading of heparin, chemical architecture of the microspheres and pH of the release medium were examined on the release profiles of the drug. The chemical stability of heparin was tested in phosphate buffer saline (pH 7.4) and the release was also studied in various simulated biological fluids.

摘要

已制备交联淀粉微球,并通过红外光谱分析和扫描电子显微镜技术对其进行了表征。将制备的微球负载抗凝血药物“肝素”,并在生理pH值(7.4)和体温(37摄氏度)下采用分光光度法研究肝素的体外释放动力学。考察了肝素负载百分比、微球化学结构和释放介质pH值对药物释放曲线的影响。在磷酸盐缓冲盐水(pH 7.4)中测试了肝素的化学稳定性,并在各种模拟生物流体中研究了其释放情况。

相似文献

1
Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.肝素从可膨胀交联淀粉微球中的控释动力学。
J Mater Sci Mater Med. 2007 Aug;18(8):1613-21. doi: 10.1007/s10856-007-3020-y. Epub 2007 May 5.
2
In vitro degradation and release profiles for Poly-dl-lactide film containing paracetamol.含对乙酰氨基酚的聚消旋乳酸薄膜的体外降解和释放曲线
J Mater Sci Mater Med. 2007 Aug;18(8):1623-6. doi: 10.1007/s10856-007-3048-z. Epub 2007 May 5.
3
Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers.通过乳液交联制备的淀粉基微球,具有潜在的介质依赖性响应行为,可用作药物递送载体。
J Mater Sci Mater Med. 2006 Apr;17(4):371-7. doi: 10.1007/s10856-006-8240-z.
4
Drug release from alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide-based microparticles.基于α,β-聚(N-2-羟乙基)-DL-天冬酰胺的微粒的药物释放
Biomaterials. 2004 Aug;25(18):4333-43. doi: 10.1016/j.biomaterials.2003.11.015.
5
Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres.非诺贝特负载的聚乳酸-聚乙二醇微球的制备与表征
J Mater Sci Mater Med. 2007 Aug;18(8):1481-7. doi: 10.1007/s10856-007-0132-3. Epub 2007 Mar 27.
6
Preparation and characterization of pH-sensitive methyl methacrylate-g-starch/hydroxypropylated starch hydrogels: in vitro and in vivo study on release of esomeprazole magnesium.pH 敏感型甲基丙烯酸甲酯接枝淀粉/羟丙基化淀粉水凝胶的制备与表征:埃索美拉唑镁释放的体外和体内研究
Drug Deliv Transl Res. 2015 Jun;5(3):243-56. doi: 10.1007/s13346-015-0221-7.
7
Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase.含与不含α-淀粉酶的淀粉醋酸酯微粒及薄膜的药物释放
Biomaterials. 2004 Aug;25(18):4355-62. doi: 10.1016/j.biomaterials.2003.11.026.
8
Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.粘合剂添加剂对α-PVA/NaCl/H₂O体系中特布他林水凝胶在药物递送中的影响:I. 明胶和可溶性淀粉的影响。
Biomed Mater Eng. 2004;14(4):371-82.
9
Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.用于药物递送应用的交联壳聚糖微球的合成与表征
J Microencapsul. 2003 May-Jun;20(3):375-85. doi: 10.1080/0265204031000093078.
10
An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles.对可膨胀聚甲基丙烯酸羟乙酯(PHEMA)纳米颗粒中5-氟尿嘧啶(5-FU)的体外释放研究。
J Mater Sci Mater Med. 2009 May;20(5):1103-14. doi: 10.1007/s10856-008-3677-x. Epub 2009 Jan 10.

引用本文的文献

1
In Vitro and In Vivo Evaluation of Epidermal Growth Factor (EGF) Loaded Alginate-Hyaluronic Acid (AlgHA) Microbeads System for Wound Healing.用于伤口愈合的负载表皮生长因子(EGF)的海藻酸盐-透明质酸(AlgHA)微珠系统的体外和体内评价
J Funct Biomater. 2023 Jul 28;14(8):403. doi: 10.3390/jfb14080403.
2
Preclinical Safety Assessment of Chemically Cross-Linked Modified Mandua Starch: Acute and Sub-Acute Oral Toxicity Studies in Swiss Albino Mice.化学交联改性曼杜阿淀粉的临床前安全性评估:瑞士白化小鼠急性和亚急性经口毒性研究
ACS Omega. 2022 Sep 28;7(40):35506-35514. doi: 10.1021/acsomega.2c01309. eCollection 2022 Oct 11.
3

本文引用的文献

1
Preparation and properties of starch-based colloidal microgels.淀粉基胶体微凝胶的制备与性质
J Colloid Interface Sci. 2002 Feb 1;246(1):48-59. doi: 10.1006/jcis.2001.8044.
2
Controlled release of heparin from polypyrrole-poly(vinyl alcohol) assembly by electrical stimulation.通过电刺激从聚吡咯-聚乙烯醇组装体中控制释放肝素。
J Biomed Mater Res A. 2005 May 1;73(2):171-81. doi: 10.1002/jbm.a.30286.
3
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment.
Improvement in Digestion Resistibility of Mandua Starch () after Cross-Linking with Epichlorohydrin.
环氧氯丙烷交联后曼陀罗淀粉()消化抗性的改善。
ACS Omega. 2022 Jul 26;7(31):27334-27346. doi: 10.1021/acsomega.2c02327. eCollection 2022 Aug 9.
4
An Investigation of Swelling Controlled Delivery of Insulin from Egg Albumin Nanocarriers.卵清蛋白纳米载体对胰岛素的肿胀控制释放研究
Iran J Pharm Res. 2016 Fall;15(4):695-711.
5
Development of subcutaneous sustained release nanoparticles encapsulating low molecular weight heparin.包封低分子量肝素的皮下缓释纳米颗粒的研制
J Adv Pharm Technol Res. 2015 Apr-Jun;6(2):58-64. doi: 10.4103/2231-4040.154531.
6
Preparation of Starch/Gelatin Blend Microparticles by a Water-in-Oil Emulsion Method for Controlled Release Drug Delivery.通过油包水乳液法制备淀粉/明胶共混微粒用于控释药物递送
Int J Biomater. 2014;2014:829490. doi: 10.1155/2014/829490. Epub 2014 Apr 29.
7
An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate) (PHEMA) nanoparticles.对可膨胀聚甲基丙烯酸羟乙酯(PHEMA)纳米颗粒中5-氟尿嘧啶(5-FU)的体外释放研究。
J Mater Sci Mater Med. 2009 May;20(5):1103-14. doi: 10.1007/s10856-008-3677-x. Epub 2009 Jan 10.
8
Key parameters affecting the initial leaky effect of hemoglobin-loaded nanoparticles as blood substitutes.影响负载血红蛋白纳米颗粒作为血液替代品的初始渗漏效应的关键参数。
J Mater Sci Mater Med. 2008 Jun;19(6):2463-70. doi: 10.1007/s10856-007-3358-1. Epub 2008 Jan 25.
淀粉/环糊精生物粘附微球的制备与表征:作为甲磺酸加贝酯(福怡)鼻腔给药治疗变应性鼻炎的平台
Biomaterials. 2004 Jan;25(1):159-70. doi: 10.1016/s0142-9612(03)00477-0.
4
Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters.含5-氟尿嘧啶的聚(D,L-丙交酯-共-乙交酯)微球:工艺参数的优化
AAPS PharmSciTech. 2003;4(2):E13. doi: 10.1208/pt040213.
5
Effects of the preparation methods of hydroxypropyl methylcellulose/polyacrylic acid blended films on drug release.羟丙基甲基纤维素/聚丙烯酸共混膜制备方法对药物释放的影响。
J Biomater Sci Polym Ed. 2003;14(1):27-44. doi: 10.1163/15685620360511128.
6
Precise control of PLG microsphere size provides enhanced control of drug release rate.对纤溶酶原激活剂(PLG)微球大小的精确控制可增强对药物释放速率的控制。
J Control Release. 2002 Jul 18;82(1):137-47. doi: 10.1016/s0168-3659(02)00136-0.
7
Formulation of epichlorohydrin cross-linked starch microspheres.环氧氯丙烷交联淀粉微球的配方。
J Microencapsul. 2001 May-Jun;18(3):373-83. doi: 10.1080/02652040010019505.
8
Factors influencing the oligonucleotides release from O-W submicron cationic emulsions.影响寡核苷酸从油包水型亚微米阳离子乳液中释放的因素。
J Control Release. 2001 Jan 29;70(1-2):243-55. doi: 10.1016/s0168-3659(00)00327-8.
9
Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant.通过一种新型的以聚乙二醇作为蛋白质微粉化辅助剂的S/O/W乳液法将蛋白质包封于可生物降解的微球中。
J Control Release. 2000 Dec 3;69(3):435-44. doi: 10.1016/s0168-3659(00)00326-6.
10
Glucose-sensitivity of glucose oxidase-containing cationic copolymer hydrogels having poly(ethylene glycol) grafts.具有聚(乙二醇)接枝的含葡萄糖氧化酶的阳离子共聚物水凝胶的葡萄糖敏感性。
J Control Release. 2000 Jun 15;67(1):9-17. doi: 10.1016/s0168-3659(00)00195-4.